Drug Candidates in Retinitis Pigmentosa Therapeutics Pipeline to Develop More as Gene Therapy: P&S Market Research

NEW YORK, March 27, 2018 -- According to a new research report titled “Retinitis Pigmentosa Therapeutics Pipeline Analysis, 2017” published by P&S Market Research, Retinitis pigmentosa currently exhibits a growing pipeline with 38 drug candidates.

Request for Sample Copy of this Research Report: https://www.psmarketresearch.com/market-analysis/retinitis-pigmentosa-therapeutics-pipeline-analysis/report-sample

Retinitis pigmentosa, also known as retinitis, is a degenerative eye disease that occurs due to the progressive degeneration of the rod photoreceptor cells in the retina of eye. The study analyzed that the retinitis pigmentosa therapeutics pipeline comprises approximately 38 drug candidates in different stages of development.

Orphan drug designations from the regulatory bodies such as Food and Drug Administration (FDA), European Medicines Agency (EMA) and Ministry of Health, Labour and Welfare (MHLW) is a key driver for the development of pipeline drugs, for treating retinitis pigmentosa. Majority of the pipeline drug candidates are being developed using the intravitreal route of administration. HORAMA S.A. is in the process of developing two phase I/II, and one Pre-Clinical therapeutics for the treatment of retinitis pigmentosa.

Browse Full Report with detailed TOC on “Retinitis Pigmentosa Therapeutics Pipeline Analysis” at: https://www.psmarketresearch.com/market-analysis/retinitis-pigmentosa-therapeutics-pipeline-analysis

Technological advancements are spurring the pipeline growth, for instance, AAV vector manufacturing platform was used in the development of AGTC-501 by the Applied Genetic Technologies Corp for the treatment of retinitis pigmentosa.

Some of the key players developing drugs for the treatment of retinitis pigmentosa include jCyte, Inc., Dompe Farmaceutici SpA, ProRetina Therapeutics, S.L., and Recursion Pharmaceuticals Inc.

More Reports Published by P&S Market Research

Hemophilia Therapeutics Pipeline Analysis - https://www.psmarketresearch.com/market-analysis/hemophilia-therapeutics-pipeline-analysis

PD-1 and PD-L1 Inhibitors Pipeline Analysis - https://www.psmarketresearch.com/market-analysis/pd1-and-pdl1-inhibitors-market

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Contact:
P&S Market Research

347, 5th Ave. #1402

New York City, NY - 10016

Toll-free: +1-888-778-7886 (USA/Canada)

Email: [email protected]

Web: https://www.psmarketresearch.com

Connect with us: LinkedIn | Twitter | Google + | Facebook